Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanamura

Showing results (501-510 of 531) with videos related to

Pageof 54
Sort By:
Cell Death Discovery|January 28, 2024
ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cellsSivasundaram Karnan, Ichiro Hanamura, Akinobu Ota, et al.
Genetics|April 4, 2000
A detailed linkage map of medaka, Oryzias latipes: comparative genomics and genome evolutionK Naruse, S Fukamachi, H Mitani, et al.
Clinical Hematology International|May 8, 2026
Guidelines and consensus for minimal residual disease-adapted therapy in multiple myeloma from the Pan-Pacific multiple myeloma working groupWenming Chen, Zhen Cai, Chor Sang Chim, et al.
Genes, Chromosomes & Cancer|October 4, 2011
Establishment of a novel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without chimeric MN1-TEL and with high expression of MN1Mayuko Gotou, Ichiro Hanamura, Hisao Nagoshi, et al.
International Journal of Hematology|June 14, 2022
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myelomaSatsuki Murakami, Masaki Ri, Masato Ito, et al.
Cell Death & Disease|March 1, 2026
Targeting fatty acid synthase suppresses tumor development in NF2/CDKN2A-deficient pleural mesotheliomaSivasundaram Karnan, Akinobu Ota, Muhammad Nazmul Hasan, et al.
FEBS Open Bio|December 8, 2018
Establishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining regionShohei Mizuno, Ichiro Hanamura, Akinobu Ota, et al.
Scientific Reports|December 2, 2020
Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicinKenji Tsuchihashi, Hitoshi Kusaba, Tomoyasu Yoshihiro, et al.
Molecular and Clinical Oncology|May 19, 2017
Programmed death-ligand 1 expression is associated with fibrosarcomatous transformation of dermatofibrosarcoma protuberansKenji Tsuchihashi, Hitoshi Kusaba, Yuichi Yamada, et al.
Cancer Research|November 13, 2020
Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of <i>ESR1</i>-Mutant Breast CancerMichelle M Williams, Nicole S Spoelstra, Spencer Arnesen, et al.
Pageof 54

Showing results (501-510 of 531) with videos related to

Sort By:
Pageof 54
Cell Death Discovery|January 28, 2024
ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cellsSivasundaram Karnan, Ichiro Hanamura, Akinobu Ota, et al.
Genetics|April 4, 2000
A detailed linkage map of medaka, Oryzias latipes: comparative genomics and genome evolutionK Naruse, S Fukamachi, H Mitani, et al.
Clinical Hematology International|May 8, 2026
Guidelines and consensus for minimal residual disease-adapted therapy in multiple myeloma from the Pan-Pacific multiple myeloma working groupWenming Chen, Zhen Cai, Chor Sang Chim, et al.
Genes, Chromosomes & Cancer|October 4, 2011
Establishment of a novel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without chimeric MN1-TEL and with high expression of MN1Mayuko Gotou, Ichiro Hanamura, Hisao Nagoshi, et al.
International Journal of Hematology|June 14, 2022
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myelomaSatsuki Murakami, Masaki Ri, Masato Ito, et al.
Cell Death & Disease|March 1, 2026
Targeting fatty acid synthase suppresses tumor development in NF2/CDKN2A-deficient pleural mesotheliomaSivasundaram Karnan, Akinobu Ota, Muhammad Nazmul Hasan, et al.
FEBS Open Bio|December 8, 2018
Establishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining regionShohei Mizuno, Ichiro Hanamura, Akinobu Ota, et al.
Scientific Reports|December 2, 2020
Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicinKenji Tsuchihashi, Hitoshi Kusaba, Tomoyasu Yoshihiro, et al.
Molecular and Clinical Oncology|May 19, 2017
Programmed death-ligand 1 expression is associated with fibrosarcomatous transformation of dermatofibrosarcoma protuberansKenji Tsuchihashi, Hitoshi Kusaba, Yuichi Yamada, et al.
Cancer Research|November 13, 2020
Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of <i>ESR1</i>-Mutant Breast CancerMichelle M Williams, Nicole S Spoelstra, Spencer Arnesen, et al.
Pageof 54